A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2007
11/22/2007	WO2007001356A3 Nanoparticles for cytoplasmic drug delivery to cancer cells
11/22/2007	WO2006110862A9 Micelle composition of polymer and passenger drug
11/22/2007	WO2006102412A3 Method and system for providing integrated medication infusion and analyte monitoring system
11/22/2007	WO2006096194A3 Drinkable immediate release tablet made with direct compression of memantine or neramexane
11/22/2007	WO2005041884A3 Polymer-based microstructures
11/22/2007	WO2002047726A3 Pharmaceutical composition containing an active with a hemolytic action and a surfactant
11/22/2007	WO2001047572A3 Device and active component for inhibiting formation of thrombus-inflammatory cell matrix
11/22/2007	US20070270630 Ingestible Device
11/22/2007	US20070270502 treatment of respiratory system disorders comprising administering non-surfactant aerosols comprising sodium chloride as a diluent and drugs selected from antibiotics, antihistamines and/or antiviral agents
11/22/2007	US20070270500 Compositions Comprising Cyclohexylamines and Aminoadamantanes
11/22/2007	US20070270491 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
11/22/2007	US20070270481 Novel combination of anticholineric and beta mimetics for the treatment of respiratory diseases
11/22/2007	US20070270378 Viscous Agent for Ophthalmic Use
11/22/2007	US20070269847 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer
11/22/2007	US20070269526 Carotenoid Composition and Method for Preparation Thereof
11/22/2007	US20070269525 O/W Gel Compositions Comprising Wax
11/22/2007	US20070269524 Use of Idrocilamide for the Preparation of a Pharmaceutical Composition of Rosacea
11/22/2007	US20070269523 Carriers Comprising Colloidal Metal Praticles for Translocation into Cerberal Neurons
11/22/2007	US20070269522 Transdermal Drug Delivery Device with Translucent Protective Film
11/22/2007	US20070269518 Light-curable bone growth material for treating dental bone defects
11/22/2007	US20070269517 Pharmaceutical Formulations for the Prolonged Release of Interferons and Their Therapeutic Applications
11/22/2007	US20070269516 Controlled release matrix
11/22/2007	US20070269515 Probiotic Tablet Formulations
11/22/2007	US20070269514 Tablet composition with a prolonged release of tamsulosin
11/22/2007	US20070269513 Liver selective drug therapy
11/22/2007	US20070269512 Gastroretentive sustained release formulations
11/22/2007	US20070269511 Solid pharmaceutical compositions containing pregabalin
11/22/2007	US20070269510 Solid Unit Dosage Forms of 5-Ht1 Agonist
11/22/2007	US20070269509 Enteric Coated Pharmaceutical Oral Formulations Comprising Acid-Labile Active Substances, and a Method Thereof
11/22/2007	US20070269508 Coenzyme Q10 Formulation and Process Methodology for Soft Gel Capsules Manufacturing
11/22/2007	US20070269507 Pharmaceutical Composition
11/22/2007	US20070269506 Oral Sustained Release Pharmaceutical Composition
11/22/2007	US20070269505 Tamper Resistant Co-Extruded Dosage Form Containing An Active Agent And An Adverse Agent And Process Of Making Same
11/22/2007	US20070269504 Amphoteric liposomes
11/22/2007	US20070269503 Combinations of HMG CoA reductase inhibitors and negatively charged phospholipids and uses thereof
11/22/2007	US20070269502 Stable Liposome Compositions Comprising Lipophilic Amine Containing Pharmaceutical Agents
11/22/2007	US20070269500 Compositions and methods for enhancing active agent absorption
11/22/2007	US20070269497 Chemical stick with soluble stabilizer
11/22/2007	US20070269496 Patch for Reducing Exposure of Skin to Ultraviolet Radiation
11/22/2007	US20070269494 Compositions and methods for enhancing active agent absorption
11/22/2007	US20070269493 Delivery of Active Agents Using A Chocolate Vehicle
11/22/2007	US20070269492 New product and use and manufacture thereof
11/22/2007	US20070269488 Hydrogel Nanocompsites for Ophthalmic Applications
11/22/2007	US20070269477 Heart Treatment Method
11/22/2007	US20070269465 Anesthetic composition for topical administration comprising lidocaine, prilocaine and tetracaine
11/22/2007	US20070269463 Botulinum toxin formulation for oral administration
11/22/2007	US20070269417 Nicotine delivery systems
11/22/2007	US20070269386 New product and use and manufacture thereof
11/22/2007	US20070269385 Devices, methods, and systems for delivering therapeutic agents for the treatment of sinusitis, rhinitis, and other disorders
11/22/2007	US20070269380 Methotrexate-modified nanoparticles and related methods
11/22/2007	US20070269379 Penetration Enhancer Combinations for Transdermal Delivery
11/22/2007	US20070269373 benz[e]indole derivatives that absorb and fluoresce in the visible region of light, particularly useful for optical diagnosis of renal and cardiac diseases and for estimation of blood volume in vivo.
11/22/2007	US20070269370 Compositions and methods for treating B-cell malignancies
11/22/2007	DE4140689B4 Inhalationspulver und Verfahren zu ihrer Herstellung Inhalable powders and methods for their preparation
11/22/2007	DE202004021399U1 Salz einer Sulfonsäure mit Clopidogrel und dessen Verwendung zur Herstellung pharmazeutischer Formulierungen Salt of a sulfonic acid with clopidogrel and its use for the preparation of pharmaceutical formulations
11/22/2007	DE102006023770A1 Treibgasfreie Aerosolformulierung für die Inhalation Propellant-free aerosol formulation for inhalation
11/22/2007	CA2654492A1 Treprostinil administration using a metered dose inhaler
11/22/2007	CA2652500A1 Coated pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent
11/22/2007	CA2652499A1 Pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent
11/22/2007	CA2652475A1 Liposome having lipid membrane containing bacterial cell component
11/22/2007	CA2652300A1 Pharmaceutical formulations of pimavanserin
11/22/2007	CA2652023A1 New form of administration of racecadotril
11/22/2007	CA2651988A1 Pharmaceutical compositions for vein irritating drugs
11/22/2007	CA2651890A1 Controlled dose drug delivery system
11/22/2007	CA2651798A1 Zero-order modified release solid dosage forms
11/22/2007	CA2651569A1 Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules
11/22/2007	CA2651283A1 Pulmonary delivery of 1.alpha.,25-dihydroxyvitamin d3 and co-administration of parathyroid hormone or calcitonin
11/22/2007	CA2650695A1 Methods for treating or preventing disorders using ecdysteroid compositions
11/22/2007	CA2649967A1 Hydrogel suspension and manufacturing process thereof
11/22/2007	CA2649124A1 Compositions comprising at least one naphthoic acid derivative and benzoyl peroxide, methods for preparing same, and uses thereof
11/22/2007	CA2635767A1 Multilayer tablet
11/22/2007	CA2628031A1 Once-daily administration of central nervous system drugs
11/21/2007	EP1857809A1 Method of measuring coating amount and method of estimating elution behavior
11/21/2007	EP1857494A1 Hydrogel for medical use
11/21/2007	EP1857489A1 Microparticle and pharmaceutical composition
11/21/2007	EP1857443A2 Therapeutic morpholino-substituted compounds
11/21/2007	EP1857120A1 Injection for mastitis
11/21/2007	EP1857114A1 Particle and preparation containing the particle
11/21/2007	EP1857113A2 Method and materials for treating asthma
11/21/2007	EP1857112A1 Anticancer composition for oral use comprising liposome containing phytosterols and prevention or treatment for cancer using the liposome
11/21/2007	EP1857103A1 Transdermally absorbable preparation
11/21/2007	EP1857102A1 Folic acid supplement
11/21/2007	EP1857101A2 Medicaments
11/21/2007	EP1856179A2 Functionalized poly (ether-anhydride) block copolymers
11/21/2007	EP1855786A2 High flux, microporous, sieving membranes and separators containing such membranes and processes using such membranes
11/21/2007	EP1855702A2 Herbal compositions for prevention and treatment of rheumatic and inflammatory diseases and method of preparing the same
11/21/2007	EP1855695A1 Solid pharmaceutical composition comprising telithromycin
11/21/2007	EP1855690A2 A tetracycline metal complex in a solid dosage form
11/21/2007	EP1855687A1 Medicament forms with controlled bioavailability
11/21/2007	EP1855683A2 A solid pharmaceutical dosage formulation
11/21/2007	EP1855674A2 Composition for inhibition of cathepsin k
11/21/2007	EP1855671A1 Oral dosage form comprising rosiglitazone
11/21/2007	EP1855669A1 Liposomal compositions for parenteral delivery of agents
11/21/2007	EP1855668A1 Novel method for obtaining a fast-dissolving imidapril powder
11/21/2007	EP1855667A1 Pharmaceutical composition comprising an indolylmaleimide derivative
11/21/2007	EP1855666A1 Dronabinol compositions and methods of using same
11/21/2007	EP1855660A1 Non-fibrous transdermal therapeutic system and method for its production
11/21/2007	EP1855659A2 Nanoparticulate formulations of docetaxel and analogues thereof
11/21/2007	EP1855658A1 Compositions comprising entrained water and agents entrained in water-sensitive matrices
11/21/2007	EP1855657A2 Dosage form containing oxycodone and naloxone

1 ... 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 ... 2991